At-Home Rapid Test Receives FDA Emergency Use Authorization

The Food and Drug Administration (FDA) issued an emergency use authorization on Monday for a rapid at-home COVID-19 test that delivers results without the use of an outside laboratory. The QuickVue At-Home COVID-19 Test must be obtained via prescription and can be used by individuals 14 and older, or individuals eight and older as long as an adult collects the nasal swab sample. The test can be prescribed by a healthcare provider for individuals who are within six days of symptom onset.